Search for a Cure
International AIDS Society Conference Starts Sunday
- Details
- Category: HIV Treatment
- Published on Thursday, 27 June 2013 00:00
- Written by Liz Highleyman
The 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) will kick of Sunday, June 30, in Kuala Lumpur Malaysia. Key areas of interest will include new developments in antiretroviral therapy, biomedical HIV prevention, and improving access to and retention in care.
30 Years of HIV: Long Road Ahead to a Cure
- Details
- Category: Search for a Cure
- Published on Thursday, 13 June 2013 00:00
- Written by Keith Alcorn
Scientists from around the world met to review the future of HIV scientific research at the Institut Pasteur in Paris, last month -- 30 years after the discovery of HIV by a team based at the institute. The prospects for a cure for HIV infection were a major theme of the meeting, which attracted around 500 scientists, chiefly from France and the United States.
Sangamo Reports Zinc Finger Gene Therapy Leads to Long-term CD4 Cell Gains, Shrinking HIV Reservoirs
- Details
- Category: Search for a Cure
- Published on Wednesday, 15 May 2013 00:00
- Written by Liz Highleyman
An experimental gene therapy technique that modifies CD4 T-cells to protect them from viral entry produced lasting CD4 cell increases with a single infusion, as well as reduction in proviral DNA reservoirs and decreased viral load in 2 patients who underwent antiretroviral therapy (ART) interruption, according to data presented this week at the 16th Annual Meeting of the American Society of Gene and Cell Therapy in Salt Lake City.
FDA to Hold Public Meeting on Patient-Focused Drug Development and HIV Cure Research
- Details
- Category: HIV Treatment
- Published on Thursday, 30 May 2013 00:00
- Written by FDA
On June 14, the U.S. Food and Drug Administration (FDA) will host a public meeting on patient-focused HIV drug development and cure-related research at its Maryland headquarters, the agency announced this month. Participants are requested to register by June 5.
Very Early Antiretroviral Therapy Does Not Prevent Immune Activation
- Details
- Category: Search for a Cure
- Published on Wednesday, 15 May 2013 00:00
- Written by Liz Highleyman
People who started antiretroviral therapy (ART) during acute HIV infection and experienced sustained viral suppression saw a substantial decrease in immune activation markers on their CD8 T-cells after 2 years of treatment, but often not to the level seen in HIV negative individuals, according to a report in the April 15, 2013, Journal of Acquired Immune Deficiency Syndromes.
More Articles...
- CROI 2013: Gene Therapy Studies Show Potential for HIV Control without Drugs
- CROI 2013: Antiretroviral Therapy Intensification plus IL-7 Does Not Reduce HIV Reservoir
- French Cohort of HIV+ People Treated Early Appear to Control Virus
- CROI 2013: Functional Cure of HIV-infected Infant after Early ART [VIDEO]